跳至主要内容
临床试验/NCT05361980
NCT05361980招募中不适用

Global Pediatric Orthopaedic Implant Safety & Efficacy Clinical Follow-up Program

University of British Columbia1 个研究点 分布在 1 个国家目标入组 4,000 人开始时间: 2022年1月6日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
4,000
试验地点
1
主要终点
Device related adverse events

研究概览

简要总结

Implant devices are important tools - their use is essential across a number of orthopaedic indications, including hip conditions, trauma and limb deformity.

Given the vital role fixation devices play in maintaining alignment, promoting healthy bone healing and preventing joint degeneration, it is essential to understand the expected lifetime outcomes of these implants, and evaluate their safety and efficacy.

Prospective implant efficacy and safety registries are needed to support this endeavour, especially considering new regulatory requirements from the European Union Medical Devices Regulation (EU MDR) in relation to post-market clinical follow-up (PMCF).

详细描述

STUDY PROCEDURES Screening Patients will be screened against basic inclusion/exclusion criteria to see if patients may be appropriate for study participation according to any standard of care assessments available, and where appropriate with the site's REB/IRB screening procedures and local regulatory requirements. If a patient is deemed eligible, data outlined throughout this protocol will be collected, de-identified and entered into a Research Electronic Database Capture (REDCap) system managed at BCCH.

Enrollment Patients will be assigned a sequential, unique study number (subject ID) and de-identified data will be entered in the study database. The center number is designated by the BCCH team for each individual investigational site. The patient number will be in sequential order by the patient screening date starting with 001. Once a patient has been assigned a subject ID, the number will not be reused.

Pre-Operative Procedures Once a patient is identified as eligible for an Implant Safety and Efficacy device report, it will be determined whether that patient is already enrolled in one of the existing condition-specific registries. Should participants be enrolled in a condition-specific registry, demographic data, medical history, preoperative clinical data, including any pre-existing infections at or near the operative site, and data on pre-operative radiographs for the relevant underlying diagnosis will have already been prospectively collected under registry procedures. If a patient has not been previously enrolled in a condition-specific registry, the patient will be offered enrollment in both the condition registry and for the purposes of the Implant Safety and Efficacy device report. Demographic data, medical history, preoperative clinical data and data on pre-operative radiographs for the relevant underlying diagnosis will then be collected retrospectively from the medical record.

Required Data Collection:

Operative details in the source documentation will be collected that provide specific information from the subject's surgery such as surgical approach, complications, and unique device identification (UDI) numbers for the implanted device.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
0 Years 至 25 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Patients indicated for the device-specific indication, per physician discretion and as indicated in the device IFU. Off-label use is strongly discouraged; however, any and all on- and off-label indications for use of the products in this program will be collected and stratified accordingly
  • Patients must be able to adhere to the required length of follow-up for the endpoints of each individual product
  • Informed consent/assent is required

排除标准

  • Patients with a demonstrated sensitivity to metals
  • Patients with an inability to follow a post-operative regimen

结局指标

主要结局

Device related adverse events

时间窗: 2 years post implant insertion

Determine the frequency and severity of device-related adverse events at device-specific end points. All adverse events will be recorded and followed during the study. The frequency and severity of device related adverse events will be analyzed to ensure the device risk profile has not changed.

Implant survival

时间窗: 2 years post implant insertion

Determine the implant survival rate at post-operative end-point: (lack of revision)

Implant efficacy

时间窗: 2 years post implant insertion

Efficacy will be assessed by post-operative clinical and radiographic evaluations at each follow-up end-point to assess bone fixation and/or deformity correction.

次要结局

  • Numeric pain rating scale (NPRS)(2 years post implant insertion)
  • LIMB-Q Kids(2 years post implant insertion)
  • PROMIS(2 years post implant insertion)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kishore Mulpuri

Professor

University of British Columbia

研究点 (1)

Loading locations...

相似试验